SCHEMBL6647477

SCHEMBL6647477

Cc1ccc(C(=O)Nc2ccc(N(CCn3nccc3NC(c3ccccc3)(c3ccccc3)c3ccccc3)C(=O)O)cc2)c(N(C)C)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CYP3A4 P08684 4/20 0.36
ALDH1A1 P00352 3/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
PDK1 Q15118 1/20 0.36
CYP2D6 P10635 1/20 0.36
MAPT P10636 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
GPR27 Q9NS67 1/20 0.34
HSD17B10 Q99714 1/20 0.33
NR3C1 P04150 1/20 0.33
AKR1C3 P42330 1/20 0.33
LMNA P02545 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6645107 0.86 KCNA5 (0.39) MEN1KMT2AALDH1A1MAPTNPC1
SCHEMBL6645963 0.85 ALDH1A1 (0.39) KMT2ACYP3A4ALDH1A1L3MBTL1NPC1
SCHEMBL6645358 0.84 GPR27 (0.37) MEN1KMT2AALDH1A1CYP2C19TDP1
SCHEMBL6645258 0.80 ALDH1A1 (0.36) MEN1KMT2AALDH1A1MAPTNPC1
SCHEMBL7201167 0.79 THRB (0.40) MEN1KMT2ACYP3A4ALDH1A1CYP1A2
SCHEMBL6648929 0.77 TAS1R3 (0.42) MEN1KMT2AALDH1A1MAPTNPC1
SCHEMBL6644367 0.76 DGAT1 (0.35) GPR27NR3C1TRPV4
SCHEMBL7201171 0.75 SCD (0.43) KMT2AALDH1A1TDP1MAPTRAB9A
SCHEMBL6644541 0.74 DGAT1 (0.37) KMT2AALDH1A1MAPTL3MBTL1NPC1
SCHEMBL6645551 0.74 KMT2A (0.38) MEN1KMT2AALDH1A1GPR27LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040133008-A1 Amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040133008-A1 Amide compounds APOB, APOL1, LDLR MEN1 3820/4885KMT2A 916/4885CYP3A4 2434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.